104 related articles for article (PubMed ID: 9737987)
1. Characterization of the aldolase B intronic enhancer.
Gregori C; Porteu A; Lopez S; Kahn A; Pichard AL
J Biol Chem; 1998 Sep; 273(39):25237-43. PubMed ID: 9737987
[TBL] [Abstract][Full Text] [Related]
2. In vivo functional characterization of the aldolase B gene enhancer.
Gregori C; Porteu A; Mitchell C; Kahn A; Pichard AL
J Biol Chem; 2002 Aug; 277(32):28618-23. PubMed ID: 12034748
[TBL] [Abstract][Full Text] [Related]
3. An enhancer element 6 kb upstream of the mouse HNF4alpha1 promoter is activated by glucocorticoids and liver-enriched transcription factors.
Bailly A; Torres-Padilla ME; Tinel AP; Weiss MC
Nucleic Acids Res; 2001 Sep; 29(17):3495-505. PubMed ID: 11522818
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization of transcription factor binding sites for HNF1-alpha, HNF3-beta (FOXA2), HNF4-alpha, Sp1 and Sp3 in the human prothrombin gene enhancer.
Ceelie H; Spaargaren-Van Riel CC; De Jong M; Bertina RM; Vos HL
J Thromb Haemost; 2003 Aug; 1(8):1688-98. PubMed ID: 12911579
[TBL] [Abstract][Full Text] [Related]
5. Site-directed mutagenesis of hepatocyte nuclear factor (HNF) binding sites in the mouse transthyretin (TTR) promoter reveal synergistic interactions with its enhancer region.
Costa RH; Grayson DR
Nucleic Acids Res; 1991 Aug; 19(15):4139-45. PubMed ID: 1870969
[TBL] [Abstract][Full Text] [Related]
6. Competition between transcription factors HNF1 and HNF3, and alternative cell-specific activation by DBP and C/EBP contribute to the regulation of the liver-specific aldolase B promoter.
Gregori C; Kahn A; Pichard AL
Nucleic Acids Res; 1993 Feb; 21(4):897-903. PubMed ID: 8383844
[TBL] [Abstract][Full Text] [Related]
7. Cellular factors controlling the activity of woodchuck hepatitis virus enhancer II.
Ueda K; Wei Y; Ganem D
J Virol; 1996 Jul; 70(7):4714-23. PubMed ID: 8676498
[TBL] [Abstract][Full Text] [Related]
8. Liver-specific expression of the human factor VII gene.
Greenberg D; Miao CH; Ho WT; Chung DW; Davie EW
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12347-51. PubMed ID: 8618898
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of a 315-base pair enhancer, located more than 55 kilobases 5' of the apolipoprotein B gene, that confers expression in the intestine.
Antes TJ; Goodart SA; Huynh C; Sullivan M; Young SG; Levy-Wilson B
J Biol Chem; 2000 Aug; 275(34):26637-48. PubMed ID: 10859308
[TBL] [Abstract][Full Text] [Related]
10. The proximal element of the human apolipoprotein A-II promoter increases the enhancer activity of the distal region.
Lacorte JM; Fourniat E; Pastier D; Chambaz J; Ribeiro A; Cardot P
Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):681-8. PubMed ID: 8809063
[TBL] [Abstract][Full Text] [Related]
11. Differential promoter usage in prolactin receptor gene expression: hepatocyte nuclear factor 4 binds to and activates the promoter preferentially active in the liver.
Møldrup A; Ormandy C; Nagano M; Murthy K; Banville D; Tronche F; Kelly PA
Mol Endocrinol; 1996 Jun; 10(6):661-71. PubMed ID: 8776726
[TBL] [Abstract][Full Text] [Related]
12. An array of binding sites for hepatocyte nuclear factor 4 of high and low affinities modulates the liver-specific enhancer for the human alpha1-microglobulin/bikunin precursor.
Rouet P; Raguenez G; Ruminy P; Salier JP
Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):577-84. PubMed ID: 9729465
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a specific region in the hepatitis B virus enhancer I for the efficient expression of X gene in the hepatic cell.
Fukai K; Takada S; Yokosuka O; Saisho H; Omata M; Koike K
Virology; 1997 Sep; 236(2):279-87. PubMed ID: 9325235
[TBL] [Abstract][Full Text] [Related]
14. Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease.
Günther S; Piwon N; Iwanska A; Schilling R; Meisel H; Will H
J Virol; 1996 Dec; 70(12):8318-31. PubMed ID: 8970951
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid mediates down-regulation of the alpha-fetoprotein gene through decreased expression of hepatocyte nuclear factors.
Magee TR; Cai Y; El-Houseini ME; Locker J; Wan YJ
J Biol Chem; 1998 Nov; 273(45):30024-32. PubMed ID: 9792724
[TBL] [Abstract][Full Text] [Related]
16. Distal apolipoprotein C-III regulatory elements F to J act as a general modular enhancer for proximal promoters that contain hormone response elements. Synergism between hepatic nuclear factor-4 molecules bound to the proximal promoter and distal enhancer sites.
Kardassis D; Tzameli I; Hadzopoulou-Cladaras M; Talianidis I; Zannis V
Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):222-32. PubMed ID: 9012660
[TBL] [Abstract][Full Text] [Related]
17. Synergistic activation of the Atlantic salmon hepatocyte nuclear factor (HNF) 1 promoter by the orphan nuclear receptors HNF4 and chicken ovalbumin upstream promoter transcription factor I (COUP-TFI).
McNair A; Cereghini S; Brand H; Smith T; Breillat C; Gannon F
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):557-64. PubMed ID: 11085951
[TBL] [Abstract][Full Text] [Related]
18. Functional dissection of the brain-specific rat aldolase C gene promoter in transgenic mice. Essential role of two GC-rich boxes and an HNF3 binding site.
Thomas M; Skala H; Kahn A; Tuy FP
J Biol Chem; 1995 Sep; 270(35):20316-21. PubMed ID: 7657603
[TBL] [Abstract][Full Text] [Related]
19. Polyunsaturated fatty acyl coenzyme A suppress the glucose-6-phosphatase promoter activity by modulating the DNA binding of hepatocyte nuclear factor 4 alpha.
Rajas F; Gautier A; Bady I; Montano S; Mithieux G
J Biol Chem; 2002 May; 277(18):15736-44. PubMed ID: 11864989
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte nuclear factor 1 alpha: a key mediator of the effect of bile acids on gene expression.
Jung D; Kullak-Ublick GA
Hepatology; 2003 Mar; 37(3):622-31. PubMed ID: 12601360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
